Literature DB >> 9246643

Effect of phosphorylation on tetramerization of the tumor suppressor protein p53.

K Sakaguchi1, H Sakamoto, D Xie, J W Erickson, M S Lewis, C W Anderson, E Appella.   

Abstract

Human tumor suppressor protein p53 is a 393-amino acid phosphoprotein that enhances transcription in response to DNA damage from several genes that regulate cell cycle progression. The tetrameric state of p53 is critical to wild-type function; the p53 tetramerization element is located in the C-terminal region of the protein. This region is phosphorylated at several evolutionarily conserved serines, suggesting that phosphorylation may be an important regulator of p53 function. In order to determine the effect of phosphorylation on tetramer formation, we synthesized phosphopeptides corresponding to p53(Ser303-Asp393) with phosphate incorporated at Ser315, Ser378, or Ser392, and at both Ser315 and Ser392. Equilibrium ultracentrifugation analysis showed that phosphorylation at Ser392 increased the association constant for tetramer formation nearly ten-fold. By itself, phosphorylation at Ser315 or Ser378 had little effect on tetramer formation, but Ser315 largely reversed the effect of phosphorylation at Ser392. Analysis by calorimetry suggests that phosphorylation may influence subunit affinity by an enthalpy driven process.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9246643     DOI: 10.1023/a:1026334116189

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  11 in total

1.  Planck-Benzinger thermal work function: thermodynamic characterization of the carboxy-terminus of p53 peptide fragments.

Authors:  Paul W Chun; Marc S Lewis
Journal:  Protein J       Date:  2010-11       Impact factor: 2.371

2.  Identification of new p53 acetylation sites in COS-1 cells.

Authors:  Anita Joubel; Robert J Chalkley; Katalin F Medzihradszky; Hubert Hondermarck; Alma L Burlingame
Journal:  Mol Cell Proteomics       Date:  2009-01-19       Impact factor: 5.911

Review 3.  p53 RNA interactions: new clues in an old mystery.

Authors:  Kasandra J-L Riley; L James Maher
Journal:  RNA       Date:  2007-09-05       Impact factor: 4.942

Review 4.  Strategies for manipulating the p53 pathway in the treatment of human cancer.

Authors:  T R Hupp; D P Lane; K L Ball
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

5.  Increased sensitivity to UV radiation in mice with a p53 point mutation at Ser389.

Authors:  Wendy Bruins; Edwin Zwart; Laura D Attardi; Tomoo Iwakuma; Esther M Hoogervorst; Rudolf B Beems; Barbara Miranda; Conny T M van Oostrom; Jolanda van den Berg; Gerard J van den Aardweg; Guillermina Lozano; Harry van Steeg; Tyler Jacks; Annemieke de Vries
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

6.  UVB-mediated activation of p38 mitogen-activated protein kinase enhances resistance of normal human keratinocytes to apoptosis by stabilizing cytoplasmic p53.

Authors:  Nadine Chouinard; Kristoffer Valerie; Mahmoud Rouabhia; Jacques Huot
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

7.  Methylation-acetylation interplay activates p53 in response to DNA damage.

Authors:  Gleb S Ivanov; Tatyana Ivanova; Julia Kurash; Alexey Ivanov; Sergey Chuikov; Farid Gizatullin; Enrique M Herrera-Medina; Frank Rauscher; Danny Reinberg; Nickolai A Barlev
Journal:  Mol Cell Biol       Date:  2007-07-23       Impact factor: 4.272

8.  p53 Stabilization and accumulation induced by human vaccinia-related kinase 1.

Authors:  Francisco M Vega; Ana Sevilla; Pedro A Lazo
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

9.  Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors.

Authors:  David H Dreyfus; Masayuki Nagasawa; Erwin W Gelfand; Lucy Y Ghoda
Journal:  BMC Immunol       Date:  2005-06-21       Impact factor: 3.615

10.  Structure and Function of p53-DNA Complexes with Inactivation and Rescue Mutations: A Molecular Dynamics Simulation Study.

Authors:  Balu Kamaraj; Annemie Bogaerts
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.